On Friday, Windtree Therapeutics Inc (NASDAQ: WINT) was -6.02% drop from the session before settling in for the closing price of $0.34. A 52-week range for WINT has been $0.29 – $14.75.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -25.00%. When this article was written, the company’s average yearly earnings per share was at 94.00%. With a float of $8.94 million, this company’s outstanding shares have now reached $8.99 million.
Let’s determine the extent of company efficiency that accounts for 15 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Windtree Therapeutics Inc (WINT) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Windtree Therapeutics Inc stocks. The insider ownership of Windtree Therapeutics Inc is 0.52%, while institutional ownership is 1.81%. The most recent insider transaction that took place on Oct 08 ’24, was worth 4,942. In this transaction President and CEO of this company bought 5,431 shares at a rate of $0.91, taking the stock ownership to the 8,638 shares.
Windtree Therapeutics Inc (WINT) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 94.00% per share during the next fiscal year.
Windtree Therapeutics Inc (NASDAQ: WINT) Trading Performance Indicators
You can see what Windtree Therapeutics Inc (WINT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -18.63, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -2.86 in one year’s time.
Technical Analysis of Windtree Therapeutics Inc (WINT)
Looking closely at Windtree Therapeutics Inc (NASDAQ: WINT), its last 5-days average volume was 4.7 million, which is a drop from its year-to-date volume of 8.68 million. As of the previous 9 days, the stock’s Stochastic %D was 44.11%. Additionally, its Average True Range was 0.05.
During the past 100 days, Windtree Therapeutics Inc’s (WINT) raw stochastic average was set at 0.19%, which indicates a significant decrease from 19.84% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 94.87% in the past 14 days, which was lower than the 203.87% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5097, while its 200-day Moving Average is $3.8423. However, in the short run, Windtree Therapeutics Inc’s stock first resistance to watch stands at $0.3470. Second resistance stands at $0.3755. The third major resistance level sits at $0.3929. If the price goes on to break the first support level at $0.3011, it is likely to go to the next support level at $0.2837. Should the price break the second support level, the third support level stands at $0.2552.
Windtree Therapeutics Inc (NASDAQ: WINT) Key Stats
There are 11,049K outstanding shares of the company, which has a market capitalization of 2.69 million. As of now, sales total 0 K while income totals -20,290 K. Its latest quarter income was 0 K while its last quarter net income were -2,750 K.
